friday tirzepatide Fridays Weight Loss: Real Facts and Figures Fridays GLP-1 Weight Loss Review

A: Glutathione is a tripeptide composed of three amino acids: glutamate, cysteine, and glycine

Anti-inflammatory Effects: BPC-157 reduces pro-inflammatory cytokines and prostaglandins without the healing-impairing effects seen with NSAIDs

The approval comes from acknowledging the drugs efficacy in lowering blood sugar levels, an essential factor in diabetes management

News provided by Eli Lilly and Company Jul 23, 2026, 06:45 ET In TRIUMPH-2, adults with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost up to an average of 49.6 lbs (20.8%) at 80 weeks In TRIUMPH-3, adults with severe obesity and established cardiovascular disease, with or without type 2 diabetes, lost up to an average of 55.8 lbs (22.6%) at 80 weeks Lilly plans to submit a Biologics License Application (BLA) for retatrutide to FDA in Q1 2027 INDIANAPOLIS, July 23, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-2 and TRIUMPH-3, two pivotal Phase 3 trials evaluating retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist

The compound bisdemethoxycurcumin was found to be the most effective in reducing MDR-1 gene expression in comparison with pure curcumin and demethoxycurcumin